Celanese to Acquire Thermoplastics Custom Compounder Omni Plastics


Celanese Corporation (NYSE: CE), a global technology and specialty
materials company, today announced the signing of a definitive agreement
for Celanese to acquire Omni Plastics and its subsidiaries, including
the distributor Resinal de Mexico.

Omni Plastics is headquartered and has a compounding facility in
Evansville, Indiana, with additional offices in Mexico City. Omni
Plastics specializes in custom compounding of various engineered
thermoplastic materials.

“Engineered thermoplastics continues to be a material of choice in
automotive, electrical and electronics, consumer goods and industrial
markets and Omni Plastics strengthens Celanese’s presence in these
strategic areas as well as brings expanded presence in office furniture,
filtration, lawn/garden, and other specialty materials applications,”
said Scott Sutton, Chief Operating Officer, Celanese. “This acquisition
further strengthens our global asset base by adding compounding capacity
in the Americas to enable Celanese to continue to support a growing and
diverse customer base.”

Celanese expects to integrate the Omni Plastics thermoplastic
compounding product portfolio (http://omniplastics.com/high-performance-products/)
and production capabilities into the Celanese engineered materials
business to include the following product brands:

  • OmniLon™ polyamide formulations for automotive, heavy truck, air
    movement, appliance, office furniture, and lawn & garden applications.
  • OmniPro™ polypropylene formulations for pump housings, wheels,
    handles, mounting brackets, levers, pressure vessels, and office
    furniture component applications.
  • OmniCarb™ polycarbonate formulations for automotive and electronic
  • OmniTech™ non-standard, custom-developed products including
    polybutylene terephthalate and acrylonitrile butadiene styrene
    formulations for applications with unique functional requirements,
    including flame retardant, conductive, wear-and-friction, and improved
    optical clarity.

Several product grades are UL-listed, FDA-compliant, NSF-compliant and
made with post-industrial material, as well as qualified with
automotive, E&E, and other original equipment manufacturers.

Celanese expects to complete the transaction early in the first quarter
of 2018, pending customary closing conditions and regulatory approvals.
Financial details of the transaction are not being disclosed at this
time. Until closing, Celanese and Omni Plastics will continue to operate
as independent businesses.

About Omni Plastics

Omni Plastics is an independent thermoplastics custom compounder
headquartered in Evansville, Indiana. With the founding principle to
distinguish itself by utilizing and maintaining ultra-modern compounding
equipment, production techniques and responsive product development,
Omni Plastics creates tight-tolerance engineered thermoplastic
formulations to meet customers’ exacting requirements.

About Celanese

Celanese Corporation is a global technology leader in the production
of differentiated chemistry solutions and specialty materials used in
most major industries and consumer applications. Our two complementary
business cores, Acetyl Chain and Materials Solutions, use the full
breadth of Celanese’s global chemistry, technology and business
expertise to create value for our customers and the corporation. As we
partner with our customers to solve their most critical business needs,
we strive to make a positive impact on our communities and the world
through The Celanese Foundation. Based in Dallas, Celanese employs
approximately 7,500 employees worldwide and had 2016 net sales of $5.4
billion. For more information about Celanese and our product offerings,
or our blog at

All registered trademarks are owned by Celanese International
Corporation or its affiliates.

Forward-Looking Statements

This release may contain “forward-looking statements,” which include
information concerning the company’s plans, objectives, goals,
strategies, future revenues or performance, capital expenditures and
other information that is not historical information. When used in this
release, the words “outlook,” “forecast,” “estimates,” “expects,”
“anticipates,” “projects,” “plans,” “intends,” “believes,” and
variations of such words or similar expressions are intended to identify
forward-looking statements. All forward-looking statements are based
upon current expectations and beliefs and various assumptions, including
the announced acquisition. There can be no assurance that the company or
its customers will realize these benefits or that these expectations
will prove correct. There are a number of risks and uncertainties that
could cause actual results to differ materially from the forward-looking
statements contained in this release, including with respect to the
acquisition. Numerous factors, many of which are beyond the company’s
control, could cause actual results to differ materially from those
expressed as forward-looking statements. Other risk factors include
those that are discussed in the company’s filings with the Securities
and Exchange Commission. Any forward-looking statement speaks only as of
the date on which it is made, and the company undertakes no obligation
to update any forward-looking statements to reflect events or
circumstances after the date on which it is made or to reflect the
occurrence of anticipated or unanticipated events or circumstances.

Investor Relations
Surabhi Varshney,
Relations – Global

W. Travis Jacobsen, +1-972-443-3750
Relations Asia (Shanghai)

Helen Zhang, +86 21 3861 9279
Relations Europe (Germany)

Jens Kurth, +49(0)69 45009 1574

Source: Celanese Corporation